Cited by 195Endometriosis Research and TreatmentEstrogen and related hormone effectsEndometrial and Cervical Cancer Treatments

Endometrial and endometriotic concentrations of estrone and estradiol are determined by local metabolism rather than circulating levels

Open access
Huhtinen, Kaisa, Desai, Reena, Ståhle, Mia, Salminen, Anu, Handelsman, David J., Perheentupa, Antti, Poutanen, Matti·2012·The Journal of Clinical Endocrinology & Metabolism

Abstract

CONTEXT: Aberrant estrogen synthesis and metabolism have been suggested to increase local estradiol (E2) concentration in endometriosis and thus to promote the growth of the lesions. However, tissue estrogen concentrations within the endometrium and different types of endometriosis lesions have not been described. OBJECTIVE: The aim of the study was to evaluate local E2 and estrone (E1) concentrations in the endometrium and different types of endometriosis lesions, and to correlate them with the expression of estrogen-metabolizing enzymes. PATIENTS: Patients with endometriosis (n = 60) and healthy controls (n = 16) participated in the study. MAIN OUTCOME MEASURES: We measured serum and tissue concentrations of E2 and E1 as well as mRNA expression of the estrogen-metabolizing enzymes. RESULTS: Endometrial or endometriotic intratissue E2 concentrations did not reflect the corresponding serum levels. In the proliferative phase, endometrial E2 concentration was five to eight times higher than in the serum, whereas in the secretory phase the E2 concentration was about half of that in the serum. Accordingly, a markedly higher E2/E1 ratio was observed in the endometrium at the proliferative phase compared with the secretory phase. In the endometriosis lesions, E2 levels were predominating over those of E1 throughout the menstrual cycle. Among the hydroxysteroid (17β) dehydrogenase (HSD17B) enzymes analyzed, HSD17B2 negatively correlated with the E2 concentration in the endometrium, and HSD17B6 was strongly expressed, especially in the deep lesions. CONCLUSIONS: Endometrial or endometriotic tissue E2 concentrations are actively regulated by local estrogen metabolism in the tissue. Thus, the inhibition of local E2 synthesis is a valid, novel approach to reduce local E2-dependent growth of endometriotic tissue.

Integrity signals

Registry

Crossref · 10.1210/jc.2012-1154

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Higher gene expression levels of HSD17B1, CYP19A1, and ESR2 in OE lesions than DE lesions and comparable HSD17B1 expression in DE to normal endometrium have been reported.

    “For example, higher gene expression levels of HSD17B1, CYP19A1, and ESR2 in OE lesions than DE lesions and the comparable HSD17B1 expression in DE to normal endometrium have been reported (Huhtinen et al., 2012).”
  • The same study reported a 6-fold higher E2 concentration in OE lesions compared with normal endometrium, but practically comparable E2 concentration in DE lesions.

    “In fact, the same study also reported a 6-fold higher E2 concentration in OE lesions as compared with normal endometrium, but practically comparable E2 concentration in DE lesions (Huhtinen et al., 2012).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Huhtinen, K., Desai, R., Ståhle, M., Salminen, A., Handelsman, D. J., Perheentupa, A., & Poutanen, M.
Affiliations
  • University of Turku (FI)
  • The University of Sydney (AU)
Corresponding author
Poutanen, Matti
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2012-11
Volume
97
Issue
11
Pages
4228-4235
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2065528753
Cited by
195
References
10
Citations by year
2026: 9 · 2025: 20 · 2024: 14 · 2023: 18 · 2022: 14 · 2021: 15 · 2020: 16 · 2019: 15 · 2018: 15 · 2017: 9 · 2016: 22 · 2015: 13 · 2014: 11 · 2013: 4
FWCI
10.46
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
  • Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
Keywords
endometriosis, endometrium, estradiol, estrone, menstrual cycle, HSD17B2, HSD17B6, hydroxysteroid dehydrogenase
MeSH terms
Adult, Endometriosis, Endometrium, Estradiol, Estrone, Female, Humans, Ovarian Diseases, Peritoneal Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review